INTAPP INC
INTANASDAQ๐ #1614 by market capEarnings Nov 2US Equity
$39.21โผ $0.31 (โ0.80%)
Live1hโฒ 0.1%
24hโผ 0.8%
7dโฒ 7.7%
14dโฒ 22.4%
30dโฒ 41.3%
1yโผ 8.1%
๐ฆMarket Cap
$3.02B
Small Cap
๐Revenue Growth (YoY)
+14.6%
Healthy
๐Gross Margin
75.8%
High
๐ตFCF Margin
23.6%
Strong
โ๏ธP/S Ratio
5.3x
Fair
Otter Score
53
Weak
๐
Analyst Ratings
Price
$39.21
Total
12
Raised
0
Lowered
2
Avg PT
$38.75
H / L
$46 / $29
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barclays | Reiterated | Underweight | 2026-08-05 | $29.00 | โ26.00% |
Truist Securities | Reiterated | Buy | 2026-08-05 | โ | โ |
Piper Sandler | Reiterated | Neutral | 2026-08-05 | $33.00 | โ15.80% |
Citigroup | Reiterated | Neutral | 2026-05-07 | โ | โ |
JP Morgan | Reiterated | Overweight | 2026-05-06 | $34.00 | โ13.30% |
UBS | Reiterated | Buy | 2026-04-23 | $46.00 | +17.30% |
Stifel | Reiterated | Buy | 2026-02-26 | โ | โ |
Raymond James | Downgraded | Outperform โ Market Perform | 2025-01-03 | $34.00 | โ13.30% |
B of A Securities | Reiterated | Buy | 2024-08-14 | โ | โ |
Oppenheimer | Downgraded | Outperform โ Perform | 2024-07-08 | $35.00 | โ10.70% |
BTIG | Reiterated | Buy | 2024-05-08 | โ | โ |
Credit Suisse | Reiterated | Outperform | 2023-05-09 | $40.00 | +2.00% |
Institution
Barclays
Reiterated ยท Underweight ยท 2026-08-05
$29.00
โ26.00%
Truist Securities
Reiterated ยท Buy ยท 2026-08-05
โ
โ
Piper Sandler
Reiterated ยท Neutral ยท 2026-08-05
$33.00
โ15.80%
Citigroup
Reiterated ยท Neutral ยท 2026-05-07
โ
โ
JP Morgan
Reiterated ยท Overweight ยท 2026-05-06
$34.00
โ13.30%
UBS
Reiterated ยท Buy ยท 2026-04-23
$46.00
+17.30%
Stifel
Reiterated ยท Buy ยท 2026-02-26
โ
โ
Raymond James
Downgraded ยท Outperform โ Market Perform ยท 2025-01-03
$34.00
โ13.30%
B of A Securities
Reiterated ยท Buy ยท 2024-08-14
โ
โ
Oppenheimer
Downgraded ยท Outperform โ Perform ยท 2024-07-08
$35.00
โ10.70%
BTIG
Reiterated ยท Buy ยท 2024-05-08
โ
โ
Credit Suisse
Reiterated ยท Outperform ยท 2023-05-09
$40.00
+2.00%
One row per institution ยท price target from the firm's latest published target